Mayoora Muthu, DO
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Oncology Hospitalist (Assistant Professor), Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2012 | West Virginia School of Osteopathic Medicine, Lewisburg, West Virginia, US, Doctor of Osteopathic Medicine, DO |
| 2006 | The Pennsylvania State University, University Park, Pennsylvania, US, Biological Sciences, BS |
Postgraduate Training
| 2024-2024 | Serious Illness Training Certification, Palliative Care, The University of Texas MD Anderson Cancer Center |
| 2023-2024 | Rice University Leadership Coaching, Leadership Training, The University of Texas MD Anderson Cancer Center |
| 2023-2024 | Leading Teams Certification, Leadership Training, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2018-2018 | Post Graduate Gastroenterology Certification, Gatroenterology, American College of Gastroenterology, Philadelphia, Pennsylvania |
| 2018-2018 | Leadership Academy: Strategic Essentials, Leadership Training, Society of Hospital Medicine 2018 Leadership Academy, Vancouver |
| 2017-2018 | Advanced Quality and Safety Improvement Sciences Certification, Quality & Safety Research Fellowship, Christiana Care Health System, Newark, Delaware |
| 2017-2017 | Post Graduate Principles of Critical Care Certification, Critical Care, Harvard Medical School, Boston, Massachusetts |
| 2015-2016 | Chief Resident, Internal Medicine, Mercy Suburban Hospital, East Norriton, Pennsylvania |
| 2015-2016 | Training in Health Policy Studies (TIPS), Health Policy, American Osteopathic Association, Glen Head, New York |
| 2014-2016 | Clinical Residency, Internal Medicine, Mercy Health System, Philadelphia, Pennsylvania |
| 2013-2014 | Clinical Internship, Internal Medicine, Mercy Health System, Philadelphia, Pennsylvania |
| 2005-2006 | Breast Cancer Research Internship, Oncology, Pennsylvania State University & Fox Chase Cancer Center, Philadelphia, Pennsylvania |
Licenses & Certifications
| 2019 | Texas Medical License |
| 2016 | American Osteopathic Board of Internal Medicine (AOBIM) |
| 2016 | DEA License |
Experience & Service
Faculty Academic Appointments
Trauma & Perioperative Hospitalist, Department of Internal Medicine, Christiana Care Health System in Newark, Newark, DE, 2017 - 2019
Academic Hospitalist (Instructor), Department of Internal Medicine, Christiana Care Health System in Newark, Newark, DE, 2016 - 2019
Administrative Appointments/Responsibilities
Operational Medical Director, Medical Oncology Throughput, The University of Texas MD Anderson Cancer Center, 2023 - Present
Co-Chair, Advance Practice Practitioner Education, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present
Chair, Oncology Hospital Medicine Challenging Cases, The University of Texas MD Anderson Cancer Center, 2020 - 2024
Inpatient Medical Director, COVID Unit Operations, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - 2023
Hospitalist Lead, Patient Continuity Tiger Team, Christiana Care Health System, Newark, DE, 2018 - 2019
Advisory Council Member, Department of Hospital Medicine, Christiana Care Health System, Newark, DE, 2017 - 2018
Ambassador, Advanced Safety and Quality Improvement, Christiana Care Health System, Newark, DE, 2017 - 2018
Hospitalist Lead, GI Clinical Pathway Development Committee, Christiana Care Health System, Newark, DE, 2017 - 2018
Hospitalist Lead, Patient Distribution Committee, Christiana Care Health System, Newark, DE, 2017 - 2019
Medical Student Clinical Preceptor, Thomas Jefferson University, Sidney Kimmel Medical College, Christiana Care Health System, Newark, DE, 2016 - 2019
Chief Resident, Internal Medicine, Mercy Suburban Hospital, East Norriton, PA, 2015 - 2016
Resident Representative, Safety and Quality Assurance Committee, Mercy Suburban Hospital, East Norriton, DE, 2014 - 2016
Other Professional Positions
Operational Medical Director, Medical Oncology Throughput, The University of Texas MD Anderson Cancer, 2023 - Present
Inpatient Medical Director - COVID Unit Operations, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2023
Clinical Preceptor, Drexel University Nurse Practitioner, Christiana Care Health System in Newark, Newark, DE, 2018 - 2019
Teaching Assistant, Anatomy & Physiology, Greenbrier Valley Community College, Lewisburg, WV, 2009 - 2010
Creative Medical Writer & Project Assistant for Healthcare Market Development Team, Synergy Medical Education, Conshohocken, PA, 2007 - 2008
Molecular Biologist, Charles River Laboratories, Malvern, PA, 2007 - 2007
Extramural Institutional Committee Activities
Hospitalist Lead, Medical Triage Nurse & Geolocalization Implementation Taskforce, The University of Texas MD Anderson Cancer Center, 2024 - Present
Hospitalist Lead, Multidisciplinary Rounds (MDR) 2.0 Implementation Taskforce, The University of Texas MD Anderson Cancer Center, 2024 - Present
Hospitalist Lead, Medical Oncology Throughput Initiatives, The University of Texas MD Anderson Cancer Center, 2024 - Present
Committee Member, Mucositis Committee, Multinational Association of Supportive Care in Cancer (MASCC), 2023 - Present
Hospitalist Lead, Covid-19 Patient Decision-Aid Development Team, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Lead, Covid-19 Monoclonal Antibody Protocol Workgroup, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Lead, Covid-19 Taskforce for Procedural Protocol Development, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Lead, Covid-19 Visitation Policy Development Taskforce, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Lead, Covid-19 Survivorship Initiative, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Lead, Anti-Cytokine Therapy in COVID subcommittee, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Lead, Covid-19 PPE Stewardship Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Representative and Voting Member, DoIM Education Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Lead, Covid-19 Decentralization Taskforce, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Co-Lead, COVID Transitions of Care Taskforce, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Lead, Covid-19 Order Set Development Taskforce, The University of Texas MD Anderson Cancer Center, 2020 - 2020
Hospitalist Lead, COVID Treatment Algorithm Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Co-Chair, COVID Multidisciplinary Education Series, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Hospitalist Lead, COVID Goals Concordant Care Taskforce, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Inpatient Workflow Lead, Therapeutic Duplication Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Honors & Awards
| 2023 - Present | Excellence in Education Award Nominee, The University of Texas MD Anderson Cancer Center |
| 2022 | Excellence in Patient Care Award Nominee, MD Anderson Cancer Center |
| 2010 - 2012 | S.E.A.R.C.H. Scholarship Award, West Virginia Area Health Education Center |
| 2008 - 2010 | T.O.U.C.H. Community Service Award, West Virginia School of Osteopathic Medicine |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2018. Reimagining Inpatient PPI Usage. Conference. Reimagining Inpatient PPI Usage. Newark, DE, US.
- 2018. “Improving Timely Antibiotic De-escalation in Septic. Conference. “Improving Timely Antibiotic De-escalation in Septic. Newark, DE, US.
- 2015. “An Unusual Cause of Nasopharyngeal Carcinoma”. Conference. “An Unusual Cause of Nasopharyngeal Carcinoma”. Tampa, FL, US.
- 2006. “The Effects of Human Chorionic Gonadotropin on MCF. Conference. “The Effects of Human Chorionic Gonadotropin on MCF. York College, PA, US.
National Presentations
- 2022. Goal Concordant Care in COVID-19 Patients with Cancer. Goal Concordant Care in COVID-19 Patients with Cancer, US.
- 2020. COVID Care in the Cancer Population. Conference. COVID Care in the Cancer Population. Houston, TX, US.
Formal Peers
- 2025. Medical Oncology Throughput Operational Overview, US.
- 2025. Hospital Inpatient Flow Effectiveness & Throughput Retreat. Houston, Texas, US.
- 2024. Medical Oncology Inpatient Flow Effectiveness Overview. Houston, Texas, US.
- 2023. Risk factors for severe Covid-19 disease & mortality among patients with cancer. Houston, Texas, JP.
- 2022. D3Code Data Extraction in Covid-19 patients within a cancer institution. Houston, Texas, US.
- 2022. Post-acute Covid Syndrome. Houston, Texas, US.
- 2022. Goal Concordant Care in COVID-19 Patients with Cancer. Houston, Texas, US.
- 2021. Covid Operations: The MD Anderson Hospitalist Experience, US.
- 2021. Caring for the Covid Patient: An Onco-Hospitalist’s Perspective. Houston, Texas, US.
- 2020. Making COVID History: The MD Anderson Experience. Houston, Texas, US.
- 2020. COVID Care in the Cancer Population. Invited. Houston, TX, US.
- 2020. Updates in COVID-19. Newark, DE, US.
Selected Publications
Peer-Reviewed Articles
- Manzano, JM, Sahar, H, Aldrich, J, Lu, M, Shoukier, M, Peterson, CB, Dickson, KB, Koom-Dadzie, K, Kheder, E, Franco Vega, M, Mohammed, AD, Muthu, M, Simbaqueba Clavijo, CA, Senechalle, MS, Brito-Dellan, N. Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service. Supportive Care in Cancer 32(3), 2024. e-Pub 2024. PMID: 38366007.
- Muthu, M, Dalal, S, George, MC, Clavijo, CS, Lenz, CA, Nortje, N. The importance of facilitating goal-concordant care (GCC) in a pandemic. Supportive Care in Cancer 31(12), 2023. e-Pub 2023. PMID: 37906311.
- Noh, S, Bertini, CD, Mira-Avendano, I, Kaous, M, Patel, B, Faiz, S, Shannon, VR, Balachandran, D, Bashoura, L, Adachi, R, Evans, S, Dickey, BF, Wu, CC, Shroff, G, Manzano, JM, Granwehr, BP, Holloway, S, Dickson, KB, Mohammed, AD, Muthu, M, Song, H, Aroe, A, Aloia, TA, Lee Andrews, II, Badami, KK, Beird, H, Brock, K, Cata, JP, Dabaja, BS, Draetta, G, French, KE, Godoy, M, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Musunuru, TN, Nates, JL, Palaskas, NL, Ravi, V, Scheet, PA, Shete, S, Subbiah, IM, Tawbi, H, Woodman, SE, Chung, C, Khawaja, F, Sheshadri, A. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer. Cancer medicine 12(17):17753-17765, 2023. e-Pub 2023. PMID: 37592894.
- Muthu M, Dalal S, George M, Clavijo CS, Lenz C, Nortje N. The Importance of Facilitating Goal-Concordant Care (GCC) in a Pandemic: The MD Anderson Experience with hospitalized COVID-19 positive patients. Res Sq, 2023. e-Pub 2023. PMID: 37398052.
- Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. e-Pub 2023. PMID: 36868753.
- Greenbaum U, Klein K, Martinez F, Song J, Thall PF, Ramdial JL, Knape C, Aung FM, Scroggins J, Knopfelmacher A, Mulanovich V, Borjan J, Adachi J, Muthu M, Leung C, Medina MC, Champlin R, Olson A, Alousi A, Rezvani K, Shpall EJ. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients. Front Immunol 12:675679, 2021. e-Pub 2021. PMID: 33995420.
- John TM, Malek AE, Mulanovich VE, Adachi JA, Raad II, Hamilton AR, Shpall EJ, Rezvani K, Aitken SL, Jain N, Klein K, Martinez F, Jacob CN, Cherian SV, Manzano JM, Muthu M, Wegner R. Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc 95(9):2038-2040, 2020. e-Pub 2020. PMID: 32861345.
Other Articles
- Manzano JM, Muthu M, Kheder E, Mohammed A, Halm J, Dickson K, Ali N, Leung C, Koom-Dadzie K, Rubio D, Odaro O, Sibille M, Etchegaray M, Wilson K, Lin H, George M Hospitalization characteristics and outcomes of patients with cancer and COVID-19 at a comprehensive cancer center. Support Care Cancer 30(9):7783-7788, 2022. PMID: 35705751.
Abstracts
- Manzano J, Muthu M. Risk factors for severe Covid-19 disease and mortality among patients with cancer. Multinational Association of Supportive Care in Cancer Care (MASCC)/International Society for Oral Oncology (ISOO) 2023 Annual Conference, 2023.
- Reddy, Raja D, Muthu, Mayoora, Cuenca, John, Wegner, Robert, Crommett, John, Gutierrez, Cristina, Haque, Sajid, Botdorf, Joshua, Rathi, Nisha, Manjappachar, Nirmala, Sajith, Bilja, Nates, Joseph. End-of-Life Care and Clinical Characteristics of Non-survivor Cancer Patients With COVID-19. Critical Care Medicine(50(1)):259, 2022. e-Pub 2022.
- Reddy R, Muthu M. End-of-Life Care and Clinical Characteristics of Non-survivor Cancer Patients With COVID-19. 51st Critical Care Congress, 2022.
- Noh S, Muthu M. Interstitial lung disease after Covid-19 in patients with cancer and without: A prospective cohort study. CHEST Conference, 2022.
- Sahar HN, Aldrich J, Peterson CB, Brito-Dellan N, Lu M, Shoukier M, Dickson K, Koom-Dadzie K, Kheder E, Franco-Vega M, Mohammed A, Muthu M, Simbaqueba C, Sibille M, Manzano JM. Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes. Journal of Clinical Oncology(39:15), 2021. e-Pub 2021.
- Joy Davis, Brandilyn Monene, Robert Wegner, John Crommett, Mayoora Muthu, Joseph Nates, Dereddi Raja Reddy. COVID-19 L-Phenotype Treatment Approach. Critical Care Medicine(49(1)):104, 2021. e-Pub 2021.
- Brandilyn Monene, Joy Davis, John Crommett, Robert Wegner, Mayoora Muthu, Joseph Nates, Dereddi Raja Reddy. COVID-19 Pneumonitis with HLH features. Critical Care Medicine(49(1)):85, 2021. e-Pub 2021.
- Dereddi Raja Reddy, Robert Wegner, John Crommett, Mayoora Muthu, Ed Kheder, Joanna-Grace Manzano, Cerena Leung, Nisha Rathi, Cristina Gutierrez, Nirmala Manjappachar, John Cuenca, Kristen Price, Joseph Nates. First Surge COVID-19 Experience at a Comprehensive Cancer Center. Critical Care Medicine(49(1)):59, 2021. e-Pub 2021.
- Raja R, Muthu M. COVID-19 L-phenotype Treatment Approach. 50th Critical Care Congress, 2021.
- Manzano J, Muthu M. Hospitalization Characteristics and Outcomes of Patients with Cancer and COVID-19. Multinational Association of Supportive Care in Cancer Care (MASCC)/International Society for Oral Oncology (ISOO) 2021 Annual Meeting, 2021.
- Muthu M, Nortje N. Facilitating Goals of Care (GOC) Conversations in a Pandemic: THE MD ANDERSON experience with hospitalized Coronavirus disease 2019 (COVID-19) positive patients. Multinational Association of Supportive Care in Cancer Care (MASCC)/International Society for Oral Oncology (ISOO) 2021 Annual Conference, 2021.
- Reddy R, Muthu M. COVID-19 Pneumonitis with HLH features. 50th Critical Care Congress, 2021.
- Reddy R, Muthu M. First Surge COVID-19 experience at a Comprehensive Cancer Center. 50th Critical Care Congress, 2021.
- Sahar H, Muthu M. Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes. ASCO Annual Conference, 2021.
Patient Reviews
CV information above last modified December 19, 2025